NovaBay Pharmaceuticals CEO John McGovern's 2018 pay jumps 64% to $742K
NovaBay Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 19, 2019
NovaBay Pharmaceuticals reported fiscal year 2018 executive compensation information on April 19, 2019.
In 2018, four executives at NovaBay Pharmaceuticals received on average a compensation package of $462K, a 37% decrease compared to previous year.
Average pay of disclosed executives at NovaBay Pharmaceuticals
John J. McGovern, Chief Executive Officer, received $742K in total, which increased by 64% compared to 2017. 57% of McGovern's compensation, or $422K, was in option awards. McGovern also received $316K in salary and $4.4K in other compensation.
Justin M. Hall, Chief Executive Officer, received a compensation package of $572K, which decreased by 14% compared to previous year. 54% of the compensation package, or $311K, was in option awards.
Mark Sieczkarek, Chief Executive Officer, earned $345K in 2018, a 78% decrease compared to previous year.
Lewis Stuart, Former Chief Commercial Officer, received $190K in 2018, which decreases by 41% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 19, 2019.